{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:50:52Z","timestamp":1791899452146,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier","isbn-type":[{"value":"9780323994002","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["0011-1411-2020-000075"],"award-info":[{"award-number":["0011-1411-2020-000075"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["TRANSCAN456 2"],"award-info":[{"award-number":["TRANSCAN456 2"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["TRS-2016-00000371"],"award-info":[{"award-number":["TRS-2016-00000371"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["765394"],"award-info":[{"award-number":["765394"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["FI20\/00058"],"award-info":[{"award-number":["FI20\/00058"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01128"],"award-info":[{"award-number":["PI19\/01128"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00002"],"award-info":[{"award-number":["PI20\/00002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.ircmb.2022.04.017","type":"book-chapter","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T03:09:47Z","timestamp":1656299387000},"page":"117-131","source":"Crossref","is-referenced-by-count":13,"title":["Omentum: Friend or foe in ovarian cancer immunotherapy?"],"prefix":"10.1016","author":[{"given":"\u00c1ngela","family":"Bella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Arrizabalaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Augusta","family":"Di Trani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Fern\u00e1ndez-Sendin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Teijeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Salvador","family":"Russo-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/bs.ircmb.2022.04.017_bb0010","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1200\/JCO.2012.42.0505","article-title":"OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer","volume":"30","author":"Aghajanian","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0015","series-title":"Ovarian Cancer","author":"Arora","year":"2021"},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0020","series-title":"Omentum Tumors","author":"Bahar","year":"2021"},{"issue":"4","key":"10.1016\/bs.ircmb.2022.04.017_bb0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-beta signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.017_bb0030","first-page":"145","article-title":"The greater omentum: physiology and immunological concepts","volume":"43","author":"Beelen","year":"1991","journal-title":"Neth. J. Surg."},{"issue":"8794","key":"10.1016\/bs.ircmb.2022.04.017_bb0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0140-6736(92)90857-Y","article-title":"Role of omental milky spots in the local immune response","volume":"339","author":"Beelen","year":"1992","journal-title":"Lancet"},{"issue":"7542","key":"10.1016\/bs.ircmb.2022.04.017_bb0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.017_bb0045","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e58","article-title":"Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands","volume":"31","author":"Burg","year":"2020","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/carcin\/bgr230","article-title":"Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness","volume":"33","author":"Cai","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0055","first-page":"1969075","article-title":"Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response","volume":"10","author":"Cao","year":"2021","journal-title":"Onco. Targets. Ther."},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.017_bb0060","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.4049\/jimmunol.0900409","article-title":"Lymphocytes in the peritoneum home to the omentum and are activated by resident dendritic cells","volume":"183","author":"Carlow","year":"2009","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/bs.ircmb.2022.04.017_bb0065","first-page":"441","article-title":"Peritoneal carcinomatosis from ovarian epithelial primary: combined aggressive treatment","volume":"23","author":"Cavaliere","year":"2009","journal-title":"In Vivo"},{"issue":"14","key":"10.1016\/bs.ircmb.2022.04.017_bb0070","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41388-020-1194-7","article-title":"ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R\/STAT3 signaling axis","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/bs.ircmb.2022.04.017_bb0075","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/bs.ircmb.2022.04.017_bb0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ijgc-2021-002434","article-title":"Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A\/MaNGO-OV2A study","volume":"31","author":"Daniele","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2020.09.005","article-title":"Force balancing ACT-IN the tumor microenvironment: cytoskeletal modifications in cancer and stromal cells to promote malignancy","volume":"360","author":"Dawson","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.reth.2019.07.008","article-title":"Omentum a powerful biological source in regenerative surgery","volume":"11","author":"Di Nicola","year":"2019","journal-title":"Regen Ther."},{"issue":"8","key":"10.1016\/bs.ircmb.2022.04.017_bib366","doi-asserted-by":"crossref","first-page":"e23921","DOI":"10.1371\/journal.pone.0023921","article-title":"Lymphoid organ-resident dendritic cells exhibit unique transcriptional fingerprints based on subset and site","volume":"6","author":"Elpek","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.ircmb.2022.04.017_bb0095","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191869","article-title":"Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer","volume":"217","author":"Etzerodt","year":"2020","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/bs.ircmb.2022.04.017_bb0100","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.1995.13.12.2961","article-title":"Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a gynecologic oncology group pilot study","volume":"13","author":"Francis","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/bs.ircmb.2022.04.017_bb0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/bs.ircmb.2022.04.017_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002873","article-title":"Immunological configuration of ovarian carcinoma: features and impact on disease outcome","volume":"9","author":"Fucikova","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/bs.ircmb.2022.04.017_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111662","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer","volume":"11","author":"Gamboa","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.017_bb0120","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2353\/ajpath.2006.051222","article-title":"Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth","volume":"169","author":"Gerber","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/bs.ircmb.2022.04.017_bb0125","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/bs.ircmb.2022.04.017_bb0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1055-9965.EPI-04-0404","article-title":"Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer","volume":"14","author":"Gorelik","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/bs.ircmb.2021.01.004","article-title":"Implications of microgravity-induced cell signaling alterations upon cancer cell growth, invasiveness, metastatic potential, and control by host immunity","volume":"361","author":"Gregg","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/bs.ircmb.2022.04.017_bb0140","first-page":"687","article-title":"Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice","volume":"53","author":"Hagiwara","year":"1993","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.017_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000979","article-title":"M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer","volume":"8","author":"Hensler","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.017_bb0150","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10147-021-01866-3","article-title":"Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III-IV epithelial ovarian cancer","volume":"26","author":"Iwagoi","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0155","article-title":"Multimodal immunostimulation to control BRCA1-defective ovarian carcinoma. Trends","author":"Klapp","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0160","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s42003-020-01246-z","article-title":"Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1","volume":"3","author":"Krishnan","year":"2020","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/bs.ircmb.2022.04.017_bb0165","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"Suppl 4","key":"10.1016\/bs.ircmb.2022.04.017_bb0170","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Ledermann","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1\u20132","key":"10.1016\/bs.ircmb.2022.04.017_bb0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2014.12.011","article-title":"Activated type 2 innate lymphoid cells regulate beige fat biogenesis","volume":"160","author":"Lee","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1084\/jem.20181170","article-title":"Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum","volume":"216","author":"Lee","year":"2019","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/bs.ircmb.2022.04.017_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","article-title":"Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation","volume":"11","author":"Lewis","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"36","key":"10.1016\/bs.ircmb.2022.04.017_bb0190","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1200\/JCO.2016.67.1891","article-title":"Randomized phase II trial of Seribantumab in combination with paclitaxel in patients with advanced platinum-resistant or -refractory ovarian cancer","volume":"34","author":"Liu","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/bs.ircmb.2022.04.017_bb0195","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/JLB.5MIR0720-271RR","article-title":"Specialized immune responses in the peritoneal cavity and omentum","volume":"109","author":"Liu","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0200","article-title":"The essential involvement of the Omentum in the peritoneal defensive mechanisms during intra-abdominal sepsis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/bs.ircmb.2022.04.017_bb0205","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.1992.10.9.1485","article-title":"Phase I trial of intraperitoneal taxol: a Gynecoloic oncology group study","volume":"10","author":"Markman","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/bs.ircmb.2022.04.017_bb0210","doi-asserted-by":"crossref","first-page":"43481","DOI":"10.18632\/oncotarget.16480","article-title":"Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy","volume":"8","author":"McMullen","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.017_bb0215","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2009.04.005","article-title":"Lymphoid organs for peritoneal cavity immune response: milky spots","volume":"30","author":"Mebius","year":"2009","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/bs.ircmb.2022.04.017_bb0220","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.it.2017.03.002","article-title":"Immunological functions of the Omentum","volume":"38","author":"Meza-Perez","year":"2017","journal-title":"Trends Immunol."},{"issue":"i-vii","key":"10.1016\/bs.ircmb.2022.04.017_bb0225","first-page":"1","article-title":"Serosal membranes (pleura, pericardium, peritoneum). Normal structure, development and experimental pathology","volume":"183","author":"Michailova","year":"2006","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.017_bb0230","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI117933","article-title":"The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer","volume":"95","author":"Negus","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/bs.ircmb.2022.04.017_bb0235","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/bs.ircmb.2022.04.017_bb0240","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1158\/1078-0432.CCR-20-3605","article-title":"The anti-HER3 mAb Seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions","volume":"27","author":"Odintsov","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","article-title":"Focus on epithelial ovarian cancer","volume":"5","author":"Ozols","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0250","first-page":"1935104","article-title":"Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients","volume":"10","author":"Paijens","year":"2021","journal-title":"Onco. Targets. Ther."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0255","first-page":"1870811","article-title":"Tumors exploit CXCR4(hi)CD62L(lo) aged neutrophils to facilitate metastatic spread","volume":"10","author":"Peng","year":"2021","journal-title":"Onco. Targets. Ther."},{"issue":"26","key":"10.1016\/bs.ircmb.2022.04.017_bb0260","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/bs.ircmb.2022.04.017_bb0265","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ccell.2020.11.009","article-title":"Immunomodulation by targeted anticancer agents","volume":"39","author":"Petroni","year":"2021","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.017_bb0270","first-page":"169","article-title":"The omentum","volume":"6","author":"Platell","year":"2000","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/bs.ircmb.2022.04.017_bb0275","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2009.03.014","article-title":"Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens","volume":"30","author":"Rangel-Moreno","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/bs.ircmb.2022.04.017_bb0280","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1535-7163.MCT-20-0412","article-title":"Neutralization of TGFbeta improves tumor immunity and reduces tumor progression in ovarian carcinoma","volume":"20","author":"Roane","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.017_bb0285","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/bs.ircmb.2022.04.017_bb0290","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ajpath.2013.06.030","article-title":"Generation of a dual-functioning antitumor immune response in the peritoneal cavity","volume":"183","author":"Sedlacek","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.017_bb0295","first-page":"90","article-title":"Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity","volume":"26","author":"Shimotsuma","year":"1993","journal-title":"Lymphology"},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0305","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12885-019-5757-3","article-title":"Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer","volume":"19","author":"Sopo","year":"2019","journal-title":"BMC Cancer"},{"issue":"2\u20133","key":"10.1016\/bs.ircmb.2022.04.017_bb0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12026-009-8100-2","article-title":"Omental immune aggregates and tumor metastasis within the peritoneal cavity","volume":"45","author":"Sorensen","year":"2009","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/bs.ircmb.2022.04.017_bb0315","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.017_bb0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/carcin\/bgz083","article-title":"The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression","volume":"41","author":"Tang","year":"2020","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/bs.ircmb.2022.04.017_bb0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1369\/0022155417742897","article-title":"Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review","volume":"66","author":"van Baal","year":"2018","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0330","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"issue":"26","key":"10.1016\/bs.ircmb.2022.04.017_bb0335","doi-asserted-by":"crossref","first-page":"42262","DOI":"10.18632\/oncotarget.15040","article-title":"Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/bs.ircmb.2022.04.017_bb0340","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41416-019-0718-9","article-title":"Improved early detection of ovarian cancer using longitudinal multimarker models","volume":"122","author":"Whitwell","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/bs.ircmb.2022.04.017_bb0345","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0350","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijc.25961","article-title":"The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer","volume":"130","author":"Yamamura","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/bs.ircmb.2022.04.017_bb0355","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0360","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","article-title":"Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion","volume":"303","author":"Zhang","year":"2011","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/bs.ircmb.2022.04.017_bb0365","first-page":"1901464","article-title":"An efficient prognostic immune scoring system for colorectal cancer patients with peritoneal metastasis","volume":"10","author":"Zhao","year":"2021","journal-title":"Onco. Targets. Ther."}],"container-title":["International Review of Cell and Molecular Biology","Cellular Immunity in the Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644822000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644822000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T13:36:47Z","timestamp":1682948207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644822000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323994002"],"references-count":73,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2022.04.017","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}